Cargando…
Overexpression of CD44 Variant 9: A Novel Cancer Stem Cell Marker in Human Cholangiocarcinoma in Relation to Inflammation
Various CD44 isoforms are expressed in several cancer stem cells during tumor progression and metastasis. In particular, CD44 variant 9 (CD44v9) is highly expressed in chronic inflammation-induced cancer. We investigated the expression of CD44v9 and assessed whether CD44v9 is a selective biomarker o...
Autores principales: | Suwannakul, Nattawan, Ma, Ning, Thanan, Raynoo, Pinlaor, Somchai, Ungarreevittaya, Piti, Midorikawa, Kaoru, Hiraku, Yusuke, Oikawa, Shinji, Kawanishi, Shosuke, Murata, Mariko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198546/ https://www.ncbi.nlm.nih.gov/pubmed/30402042 http://dx.doi.org/10.1155/2018/4867234 |
Ejemplares similares
-
Targeting fructose metabolism by glucose transporter 5 regulation in human cholangiocarcinoma
por: Suwannakul, Nattawan, et al.
Publicado: (2021) -
CD44v9 Induces Stem Cell-Like Phenotypes in Human Cholangiocarcinoma
por: Suwannakul, Nattawan, et al.
Publicado: (2020) -
Overexpression of Insulin Receptor Substrate 1 (IRS1) Relates to Poor Prognosis and Promotes Proliferation, Stemness, Migration, and Oxidative Stress Resistance in Cholangiocarcinoma
por: Kaewlert, Waleeporn, et al.
Publicado: (2023) -
Oxidative Stress and Its Significant Roles in Neurodegenerative Diseases and Cancer
por: Thanan, Raynoo, et al.
Publicado: (2014) -
Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression
por: Armartmuntree, Napat, et al.
Publicado: (2021)